| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.006 |